Taiwan FDA registration 3249b0206ecf227b191ccbcc05d6a068

"Ruijun" respiratory fusion cell virus and adenovirus rapid test reagent (unsterilized)

TW: "睿軍" 呼吸道融合細胞病毒及腺病毒快速檢驗試劑 (未滅菌)

Taiwan·Risk Class 1·RAPIGEN INC.·Registered Dec 14, 2017 – Dec 14, 2022Cancelled

Registration details

Analysis ID: 3249b0206ecf227b191ccbcc05d6a068
Customs Code: DHA09401860909

Company information

Manufacturer: RAPIGEN INC.
Manufacturer Country: Korea, Republic of
Authorized Representative: Medley Limited

Product details

Intended Use: Limited to the first level of identification range of "respiratory fusion cell virus serum reagent (C.3480)" and "adenovirus serum reagent (C.3020)" under the management measures for medical devices.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3020 腺病毒血清試劑;; C.3480 呼吸道融合細胞病毒血清試劑
Import Information: import

Dates and status

Registration Date: Dec 14, 2017
Expiry Date: Dec 14, 2022
Cancellation Date: Apr 12, 2024

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Ruijun" respiratory fusion cell virus and adenovirus rapid test reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3249b0206ecf227b191ccbcc05d6a068 and manufactured by RAPIGEN INC.. The authorized representative in Taiwan is Medley Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.